吸烟者血浆PTX3升高与肺气肿及死亡率相关
该研究在吸烟者(含慢阻肺)中探讨PTX3基因表达与血浆水平同肺气肿、肺功能及生存的关系。结果发现肺组织PTX3表达与肺气肿严重度直接相关,血浆PTX3与FEV1负相关、与肺气肿严重度和死亡率正相关,两个调控变异与较低肺气肿和气流阻塞风险相关。
要点
- 肺组织PTX3表达与肺气肿严重度直接相关(p<0.0001)。
- 血浆PTX3与FEV1负相关(p=0.006),与肺气肿严重度(p=0.004)和死亡率(p=0.008)正相关。
- PTX3调控变异与较低肺气肿和气流阻塞风险相关,血浆PTX3与透明质酸水平相关。
核心结论
- 吸烟者肺和血PTX3水平及调控变异与气流阻塞严重度、肺气肿和死亡率存在强且重叠的关联。
- PTX3作为预测生物标志物值得进一步探索。
研究设计与样本
- 使用独立平台和队列,纳入当前和既往吸烟者(伴或不伴慢阻肺)。
- 分析肺组织PTX3基因表达和血浆PTX3与定量CT肺气肿、肺功能、症状及生存的关联。
- 检查两个PTX3基因调控变异与慢阻肺表现的关系,并分析血浆PTX3与透明质酸水平的关系。
主要发现
- 肺组织PTX3基因表达与肺气肿严重度直接相关(p<0.0001)。
- 循环PTX3水平与FEV1负相关(p=0.006)。
- 循环PTX3水平与肺气肿严重度正相关(p=0.004)。
- 循环PTX3水平与死亡率正相关(p=0.008)。
- 两个PTX3基因调控变异与较低肺气肿和呼气气流阻塞风险相关,血浆PTX3与透明质酸水平相关。
关键数值与推荐
- 肺组织PTX3表达与肺气肿严重度:p<0.0001。
- 血浆PTX3与FEV1:p=0.006(负相关)。
- 血浆PTX3与肺气肿严重度:p=0.004(正相关)。
- 血浆PTX3与死亡率:p=0.008(正相关)。
临床怎么用
- 提示PTX3可能作为吸烟相关肺病(肺气肿、气流阻塞)和死亡风险的预测生物标志物,但需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pentraxin 3 (PTX3) influences innate immunity and inflammation, host defence, the complement cascade and angiogenesis. PTX3 expression in lung and blood of subjects with tobacco exposure, and its potential relationship with disease pattern and clinical outcome are poorly understood. METHODS: Using independent platforms and cohorts, we identified associations of PTX3 gene expression in lung tissue and plasma from current and former tobacco smokers (with and without chronic obstructive pulmonary disease, COPD) to disease phenotypes including quantitative CT determined emphysema, lung function, symptoms and survival. Two putative regulatory variants of the PTX3 gene were examined for association with COPD manifestations. The relationship between plasma PTX3 and hyaluronic acid levels was further examined. RESULTS: PTX3 gene expression in lung tissue was directly correlated with emphysema severity (p<0.0001). Circulating levels of PTX3 were inversely correlated with FEV1 (p=0.006), and positively associated with emphysema severity (p=0.004) and mortality (p=0.008). Two PTX3 gene regulatory variants were associated with a lower risk for emphysema and expiratory airflow obstruction, and plasma levels of PTX3 and hyaluronic acid were related. CONCLUSIONS: These data show strong and overlapping associations of lung and blood PTX3 levels, and PTX3 regulatory gene variants, with the severity of airflow obstruction, emphysema and mortality among smokers. These findings have potential implications regarding the pathogenesis of smoking-related lung diseases and warrant further exploration for the use of PTX3 as a predictive biomarker.
引用
- Zhang Y, Tedrow J, Nouraie M, et al. Elevated plasma level of Pentraxin 3 is associated with emphysema and mortality in smokers. Thorax. 2021. PMID: 33479043. doi:10.1136/thoraxjnl-2020-215356
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。